Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Gen Virol ; 98(3): 385-395, 2017 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-27902359

RESUMEN

The foot-and-mouth disease virus (FMDV) capsid precursor, P1-2A, is cleaved by FMDV 3C protease to yield VP0, VP3, VP1 and 2A. Cleavage of the VP1/2A junction is the slowest. Serotype O FMDVs with uncleaved VP1-2A (having a K210E substitution in VP1; at position P2 in cleavage site) have been described previously and acquired a second site substitution (VP1 E83K) during virus rescue. Furthermore, introduction of the VP1 E83K substitution alone generated a second site change at the VP1/2A junction (2A L2P, position P2' in cleavage site). These virus adaptations have now been analysed using next-generation sequencing to determine sub-consensus level changes in the virus; this revealed other variants within the E83K mutant virus population that changed residue VP1 K210. The construction of serotype A viruses with a blocked VP1/2A cleavage site (containing K210E) has now been achieved. A collection of alternative amino acid substitutions was made at this site, and the properties of the mutant viruses were determined. Only the presence of a positively charged residue at position P2 in the cleavage site permitted efficient cleavage of the VP1/2A junction, consistent with analyses of diverse FMDV genome sequences. Interestingly, in contrast to the serotype O virus results, no second site mutations occurred within the VP1 coding region of serotype A viruses with the blocked VP1/2A cleavage site. However, some of these viruses acquired changes in the 2C protein that is involved in enterovirus morphogenesis. These results have implications for the testing of potential antiviral agents targeting the FMDV 3C protease.


Asunto(s)
Proteínas de la Cápside/metabolismo , Cápside/metabolismo , Cisteína Endopeptidasas/metabolismo , Virus de la Fiebre Aftosa/metabolismo , Fiebre Aftosa/virología , Proteínas Virales/metabolismo , Proteasas Virales 3C , Sustitución de Aminoácidos , Animales , Antivirales/farmacología , Cápside/efectos de los fármacos , Proteínas de la Cápside/genética , Evaluación Preclínica de Medicamentos , Virus de la Fiebre Aftosa/efectos de los fármacos , Virus de la Fiebre Aftosa/genética , Ácido Glutámico/genética , Lisina/genética , Mutación , Ensamble de Virus/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA